insights_auto
Outlook: 22.2% bullish·16.7% bearish
Pumunta sa pagsusurichevron_right
A1RG34:BVMF
Argenx Se Bdr
R$165.44
0.00%
(0.00) 1D
Okt 9, 4:56:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa A1RG34...
Buksan
R$165.44
Mataas
R$165.44
Mababa
R$165.44
Mkt. cap
50.06B
Avg. na dami
59.00
Dami
8.00
Mataas nang 52-wk
R$213.15
Mababa nang 52-wk
R$143.22
Mga natitirang share
62.89M
Bilang ng mga empleyado
2K
Buksan
R$165.44
Mataas
R$165.44
Mababa
R$165.44
Mkt. cap
50.06B
Avg. na dami
59.00
Dami
8.00
Mataas nang 52-wk
R$213.15
Mababa nang 52-wk
R$143.22
Mga natitirang share
62.89M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
1 araw ang nakalipas
Argenx stock sits at EUR 736.30 after a week of mixed trial news
AD HOC NEWS
·
2 araw ang nakalipas
Argenx stock pre-market: EUR 729.20, prior close EUR 729.90
TradingView
·
3 araw ang nakalipas
argenx SE Stock 12‑Month Price Target Cut to $1192.11, Implies 28% Upside
AD HOC NEWS
·
3 araw ang nakalipas
EUR 715.90 at Lang & Schwarz: Argenx stock after-hours minus 13.72 percent versus the prior close
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Tungkol sa Argenx Se Bdr